Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S RUBIN

Showing results (861-870 of 925) with videos related to

Pageof 93
Sort By:
BMC Pulmonary Medicine|February 15, 2011
Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trialNeil C Thomson, Adalberto S Rubin, Robert M Niven, et al.
Investigative Ophthalmology & Visual Science|October 25, 2012
The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasiaFerenc B Sallo, Tunde Peto, Catherine Egan, et al.
Investigative Ophthalmology & Visual Science|August 18, 2012
"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasiaFerenc B Sallo, Tunde Peto, Catherine Egan, et al.
Cells|June 25, 2025
Wnt/PKC Signaling Inhibits Sensory Hair Cell Formation in the Developing Mammalian CochleaJoanna F Mulvaney, Erynn M Layman, Farhana Feroze-Merzoug, et al.
Cancer Biology & Therapy|January 30, 2013
Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trialJeffrey R Infante, Hendrik-Tobias Arkenau, Johanna C Bendell, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI)David R Spigel, Mark S Rubin, Victor G Gian, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Human prostate cancer model: roles of growth factors and extracellular matricesL W Chung, W Li, M E Gleave, et al.
The Science of the Total Environment|December 5, 2002
Antimicrobial residues in animal waste and water resources proximal to large-scale swine and poultry feeding operationsEnzo R Campagnolo, Kammy R Johnson, Adam Karpati, et al.
Journal of Crohn'S & Colitis|December 26, 2022
Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBDLawrence Bai, Denis Dermadi, Laurynas Kalesinskas, et al.
Archives of Environmental Health|September 17, 2004
Use of isotope ratios to identify sources contributing to pediatric lead poisoning in PeruLuke P Naeher, Carol S Rubin, Mauricio Hernandez-Avila, et al.
Pageof 93

Showing results (861-870 of 925) with videos related to

Sort By:
Pageof 93
BMC Pulmonary Medicine|February 15, 2011
Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trialNeil C Thomson, Adalberto S Rubin, Robert M Niven, et al.
Investigative Ophthalmology & Visual Science|October 25, 2012
The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasiaFerenc B Sallo, Tunde Peto, Catherine Egan, et al.
Investigative Ophthalmology & Visual Science|August 18, 2012
"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasiaFerenc B Sallo, Tunde Peto, Catherine Egan, et al.
Cells|June 25, 2025
Wnt/PKC Signaling Inhibits Sensory Hair Cell Formation in the Developing Mammalian CochleaJoanna F Mulvaney, Erynn M Layman, Farhana Feroze-Merzoug, et al.
Cancer Biology & Therapy|January 30, 2013
Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trialJeffrey R Infante, Hendrik-Tobias Arkenau, Johanna C Bendell, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI)David R Spigel, Mark S Rubin, Victor G Gian, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Human prostate cancer model: roles of growth factors and extracellular matricesL W Chung, W Li, M E Gleave, et al.
The Science of the Total Environment|December 5, 2002
Antimicrobial residues in animal waste and water resources proximal to large-scale swine and poultry feeding operationsEnzo R Campagnolo, Kammy R Johnson, Adam Karpati, et al.
Journal of Crohn'S & Colitis|December 26, 2022
Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBDLawrence Bai, Denis Dermadi, Laurynas Kalesinskas, et al.
Archives of Environmental Health|September 17, 2004
Use of isotope ratios to identify sources contributing to pediatric lead poisoning in PeruLuke P Naeher, Carol S Rubin, Mauricio Hernandez-Avila, et al.
Pageof 93